FDA issued a Warning Letter to Morton Grove Pharmaceuticals, Inc. on 2/17/2017 for a previous inspection.
483 Morton Grove Pharmaceuticals Oct 2019

483 Morton Grove Pharmaceuticals Oct 2019

$119 - Not in Stock

FDA investigators audited the Morton Grove Pharmaceuticals - Morton Grove, IL, United States facility and issued inspectional observations (via FDA 483) on 31 Oct 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 31 Oct 2019
  • Location: Morton Grove, United States
  • FEI: 1420913

Pre-Order Not Available